Edmond Atallah

697 total citations
14 papers, 314 citations indexed

About

Edmond Atallah is a scholar working on Pharmacology, Epidemiology and Oncology. According to data from OpenAlex, Edmond Atallah has authored 14 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Edmond Atallah's work include Drug-Induced Hepatotoxicity and Protection (6 papers), Liver Disease Diagnosis and Treatment (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Edmond Atallah is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (6 papers), Liver Disease Diagnosis and Treatment (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Edmond Atallah collaborates with scholars based in United Kingdom, Spain and Portugal. Edmond Atallah's co-authors include Guruprasad P. Aithal, Jane I. Grove, Ana M. Valdes, Stuart Astbury, Amrita Vijay, Ismael Álvarez‐Álvarez, M. Isabel Lucena, Rui Providência, Mohammed Qintar and Lindsay Robertson and has published in prestigious journals such as Gastroenterology, Cochrane Database of Systematic Reviews and Journal of Hepatology.

In The Last Decade

Edmond Atallah

12 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edmond Atallah United Kingdom	9	134	104	68	62	50	14	314
Sylvia Stella Amaral Brazil	5	147 1.1×	87 0.8×	94 1.4×	38 0.6×	75 1.5×	7	459
Keita Miki Japan	10	71 0.5×	75 0.7×	83 1.2×	30 0.5×	62 1.2×	25	359
Sheida Moghadamrad Switzerland	8	171 1.3×	163 1.6×	33 0.5×	70 1.1×	106 2.1×	12	347
Ling Mei China	10	103 0.8×	168 1.6×	30 0.4×	22 0.4×	38 0.8×	34	558
Yasuyuki Tamai Japan	12	136 1.0×	135 1.3×	15 0.2×	45 0.7×	89 1.8×	43	411
Ruipeng Zheng China	11	165 1.2×	93 0.9×	15 0.2×	95 1.5×	35 0.7×	21	335
Christine Yang United States	11	137 1.0×	97 0.9×	19 0.3×	26 0.4×	26 0.5×	24	435
Shunsaku Takahashi Japan	11	184 1.4×	77 0.7×	42 0.6×	48 0.8×	8 0.2×	18	392
Elisabet Sánchez Spain	11	94 0.7×	216 2.1×	25 0.4×	34 0.5×	195 3.9×	21	363

Countries citing papers authored by Edmond Atallah

Since Specialization

Citations

This map shows the geographic impact of Edmond Atallah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmond Atallah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmond Atallah more than expected).

Fields of papers citing papers by Edmond Atallah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edmond Atallah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmond Atallah. The network helps show where Edmond Atallah may publish in the future.

Co-authorship network of co-authors of Edmond Atallah

This figure shows the co-authorship network connecting the top 25 collaborators of Edmond Atallah. A scholar is included among the top collaborators of Edmond Atallah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edmond Atallah. Edmond Atallah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Atallah, Edmond, Sarah J. Welsh, Brent O’Carrigan, et al.. (2023). Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: A 10-year real-world retrospective cohort study. JHEP Reports. 5(10). 100851–100851. 24 indexed citations

Atallah, Edmond, Jane I. Grove, Colin Crooks, et al.. (2023). Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated. Journal of Hepatology. 78(5). 989–997. 29 indexed citations

Atallah, Edmond, Stuart Astbury, Jane I. Grove, et al.. (2023). Distinctive cytokine profiles in checkpoint inhibitor-induced liver injury, idiosyncratic drug-induced liver injury and autoimmune hepatitis: a potential mechanistic biomarker panel. Journal of Hepatology. 78. S127–S127. 1 indexed citations

Björnsson, Einar S., Camilla Stephens, Edmond Atallah, et al.. (2022). A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry. Liver International. 43(1). 115–126. 35 indexed citations

Atallah, Edmond, et al.. (2022). Prescription Event Monitoring of Checkpoint Inhibitor-Induced Liver Injury and Outcomes of Rechallenge: A 10-Year Experience. 32–34.

Niu, Hao, Edmond Atallah, Ismael Álvarez‐Álvarez, et al.. (2022). Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review. Drug Safety. 45(11). 1329–1348. 14 indexed citations

Astbury, Stuart, Edmond Atallah, Jane I. Grove, et al.. (2022). Tu1291: MASS CYTOMETRY IDENTIFIES A DISCRETE POPULATION OF EFFECTOR MEMORY CD8 T CELLS AS A HALLMARK OF LIVER INJURY DUE TO IMMUNE CHECKPOINT INHIBITORS. Gastroenterology. 162(7). S–1263. 1 indexed citations

Atallah, Edmond, et al.. (2022). Prescription event monitoring of checkpoint inhibitor-induced liver injury and outcomes of rechallenge: a 10-year experience. Journal of Hepatology. 77. S116–S116.

Atallah, Edmond, Ismael Álvarez‐Álvarez, Francisco Javier Cubero, et al.. (2021). Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review. Expert Opinion on Drug Metabolism & Toxicology. 17(11). 1327–1343. 12 indexed citations

10.

Atallah, Edmond, et al.. (2021). Zanubrutinib-induced liver injury: a case report and literature review. BMC Gastroenterology. 21(1). 244–244. 12 indexed citations

11.

White, Jonathan, Said Din, R Ingram, et al.. (2020). Experiences of using vedolizumab in the treatment of inflammatory bowel disease in the East Midlands UK – a retrospective observational study. Scandinavian Journal of Gastroenterology. 55(8). 907–916. 6 indexed citations

12.

Astbury, Stuart, Edmond Atallah, Amrita Vijay, et al.. (2019). Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis. Gut Microbes. 11(3). 569–580. 145 indexed citations

13.

Alabed, Samer, Ammar Sabouni, Rui Providência, et al.. (2017). Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia. Cochrane Database of Systematic Reviews. 2017(10). CD005154–CD005154. 23 indexed citations

14.

Robertson, Lindsay, Edmond Atallah, & Gerard Stansby. (2017). Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm. Cochrane Database of Systematic Reviews. 2017(1). CD010447–CD010447. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact